B. Riley
http://www.brileyco.comB. Riley provides investment banking services to wide range of companies, as well as research and trading ideas to individual and institutional clients.
View Older Stories View More Recent Stories
-
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
-
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
-
Babcock & Wilcox Enterprises Reports Second Quarter 2020 Results, Launches Strategic Organizational and Branding Initiative
-
Form 10-Q B. Riley Principal Merge For: Jun 30
-
Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley FBR on Tuesday, August 18 and Wednesday, August 19, 2020
-
Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley FBR on Tuesday, August 18 and Wednesday, August 19, 2020
-
CuriosityStream to list on Nasdaq via $331 million reverse merger deal
-
CuriosityStream to Become Public Company Through Merger with SPAC, Software Acquisition (SAQN)
-
CuriosityStream, the First Streaming Media Company Devoted to Factual Entertainment, to Become Public Company
-
Companies with NDRs 08/11
-
Companies with NDRs 08/10
-
Top U.S. mall operator Simon faces pandemic pain
-
Form 4 B. Riley Financial, Inc. For: Aug 07 Filed by: PAULSON RANDALL E
-
Form 4 B. Riley Financial, Inc. For: Aug 06 Filed by: Young Kenneth M
-
Form 4 B. Riley Financial, Inc. For: Aug 06 Filed by: RILEY BRYANT R
-
PRG's Select Rental Inventory Set to Go to Public Auction
-
Spectrum Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
CytoSorbents Reports Record Second Quarter 2020 Financial Results
-
RTW Retailwinds, Inc. Announces Execution of Asset Purchase Agreement with Sunrise Brands, LLC for the Sale of its e-Commerce Business, including the New York & Company and Fashion to Figure E-com
-
Transphorm to Commence Trading on OTC Market Under Symbol “TGAN”
-
Form 10-Q B. Riley Financial, Inc. For: Jun 30
-
Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Franchise Group (FRG) Announces Full Exercise of Underwriters' Option to Purchase 630K Share at $23.25/Sh
-
Form 8-K B. Riley Financial, Inc. For: Jul 30
-
Form 8-K B. Riley Financial, Inc. For: Jul 30
-
B. Riley Financial (RILY) Declares $0.05 Special Dividend; 0.2% Yield
-
B. Riley Financial (RILY) Raises Quarterly Dividend 20% to $0.30; 4.7% Yield
-
Franchise Group, Inc. Announces Full Exercise of Underwriters’ Option in Public Offering of Common Stock
-
Franchise Group, Inc. Announces Full Exercise of Underwriters’ Option in Public Offering of Common Stock
-
B. Riley Financial Reports Second Quarter 2020 Results; Raises Regular Dividend to $0.30 per Share and Declares Special Dividend of $0.05 per Share
-
Spectrum Pharma (SPPI) Prices 21.67M Share Common Offering at $3/Sh
-
Spectrum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Spectrum Pharma (SPPI) Announces Proposed Public Offering of Common Stock
-
Spectrum Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Spok Reports 2020 Second Quarter Operating Results; Continued Strong Wireless Trends and Operating Expense Improvements Contribute to Strong Second Quarter Net Income and EBITDA
-
Netfin Acquisition Corp. to Combine with Triterras Fintech Pte Ltd., Creating a Leading Fintech Company Focused on Global Trade and Trade Finance
-
Arcturus Therapeutics (ARCT) Prices 3.26M Share Common Offering at $53/Sh
-
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
-
Horizon Technology Finance Announces Second Quarter 2020 Financial Results
-
New York & Company Store Closing Sales Begin with Deep Discounts
-
B. Riley Financial Sets Second Quarter 2020 Earnings Release Date and Conference Call
-
These Penny Stocks Just Hit New 52-Week Highs; Now What?
-
Cytosorbents (CTSO) Prices 5.26M Common Share Offering at $9.50/Sh
-
CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock
-
Agenus To Participate in a Panel on Cell Therapy for Infectious Diseases at the B. Riley Virtual Infectious Disease Summit
-
MTBC Completes Its Largest Offering to Date, $27.6 Million of Non-Convertible Preferred Stock
-
MTBC Completes Its Largest Offering to Date, $27.6 Million of Non-Convertible Preferred Stock
-
NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020
-
Globalscape, Inc. (GSB) to be Acquired by HelpSystems for $9.50/sh
-
GlobalSCAPE and HelpSystems Sign Merger Agreement

